摘要
目的探讨Glubran2胶介入栓塞在肺癌咯血中的应用效果。方法回顾性分析山东省新汶矿业集团莱芜中心医院2009—2012年期间采取姑息治疗的30例中晚期肺癌咯血患者的临床资料,均行Glubran2胶介入栓塞治疗。结果栓塞完成即刻造影,支气管动脉为其靶动脉,均于术中成功注胶,Glubran2胶血管内铸型良好。即刻止血23例,术后4 h止血7例。术后复发1例,无一例出现脊髓损伤、窒息等严重并发症。术后6、12及24个月随诊无咯血事件。结论 Glubran2胶介入栓塞治疗肺癌咯血创伤小、安全、止血率高、复发率低。
Objective To observe the application of Glubran2 glue intervention embolization on hemoptysis in patients with lung cancer. Methods From 2009 to 2012,in Laiwu Central Hospital of Xinwen Mining Group,Shandong Province,clinical data of 30 lung cancer patients（ at middle to advanced stage） with hemoptysis who underwent palliative treatment were retrospectively analyzed,they were treated with Glubran2 glue intervention embolization. Results Angiography was completed at the end of intervention embolization,taking bronchial artery as target artery. Glubran2 glue was successfully infused during operation,with good vascular forming. In the 30 cases,23 cases got immediate hemostasis,7 cases got hemostasis after 4 hours of operation. One case reappeared hemoptysis after operation,no one occurred severe complications,such as spinal cord injury,asphyxia. After 6,12 and 24 months of follow- up,no one occurred hemoptysis. Conclusion Glubran2 glue intervention embolization is with less trauma and recurrence rate,with higher hemostasis rate,and safe in treating hemoptysis in patients with lung cancer.
出处
《实用心脑肺血管病杂志》
2014年第10期93-95,共3页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
